Chemoreflexes, sympathetic excitation, and heart failure - Challenges and opportunities

Lyle J. Olson; Virend K. Somers

doi:10.1016/j.cardfail.2013.04.006

Chemoreflexes, sympathetic excitation, and heart failure - Challenges and opportunities

Lyle J. Olson, Virend K. Somers

Cardiovascular Medicine

Research output: Contribution to journal › Editorial › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	416-418
Number of pages	3
Journal	Journal of Cardiac Failure
Volume	19
Issue number	6
DOIs	https://doi.org/10.1016/j.cardfail.2013.04.006
State	Published - Jun 2013

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.cardfail.2013.04.006

Cite this

@article{b24a938ab03040879d26b12a62874736,

title = "Chemoreflexes, sympathetic excitation, and heart failure - Challenges and opportunities",

author = "Olson, {Lyle J.} and Somers, {Virend K.}",

note = "Funding Information: L.J.O. is supported by National Institutes of Health (NIH) grants R01 AG 41676 and R01 HL AG71478 and the Mayo Foundation . V.K.S. is supported by NIH grants HL65176, UL1 RR024150, HL96071, HL114024, and HL114676 and the Mayo Foundation; has served as a consultant for Resmed, Respicardia, Neupro, Apnex Medical, Medtronic, Deshum, and Sova Pharmaceuticals; has served as a principal investigator or coinvestigator on grants from Phillips Respironics Foundation and NIH ; and works with Mayo Health Solutions on intellectual property related to sleep and obesity.",

year = "2013",

month = jun,

doi = "10.1016/j.cardfail.2013.04.006",

language = "English (US)",

volume = "19",

pages = "416--418",

journal = "Journal of Cardiac Failure",

issn = "1071-9164",

publisher = "Churchill Livingstone",

number = "6",

}

TY - JOUR

T1 - Chemoreflexes, sympathetic excitation, and heart failure - Challenges and opportunities

AU - Olson, Lyle J.

AU - Somers, Virend K.

N1 - Funding Information: L.J.O. is supported by National Institutes of Health (NIH) grants R01 AG 41676 and R01 HL AG71478 and the Mayo Foundation . V.K.S. is supported by NIH grants HL65176, UL1 RR024150, HL96071, HL114024, and HL114676 and the Mayo Foundation; has served as a consultant for Resmed, Respicardia, Neupro, Apnex Medical, Medtronic, Deshum, and Sova Pharmaceuticals; has served as a principal investigator or coinvestigator on grants from Phillips Respironics Foundation and NIH ; and works with Mayo Health Solutions on intellectual property related to sleep and obesity.

PY - 2013/6

Y1 - 2013/6

UR - http://www.scopus.com/inward/record.url?scp=84878565918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878565918&partnerID=8YFLogxK

U2 - 10.1016/j.cardfail.2013.04.006

DO - 10.1016/j.cardfail.2013.04.006

M3 - Editorial

C2 - 23743491

AN - SCOPUS:84878565918

SN - 1071-9164

VL - 19

SP - 416

EP - 418

JO - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

IS - 6

ER -

Chemoreflexes, sympathetic excitation, and heart failure - Challenges and opportunities

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this